Immunotherapy Patient Forum for the Treatment of Melanoma, Leukemia, Lymphoma, Lung and Genitourinary Cancers

November 7, 2015
8 a.m. – 1 p.m.
Gaylord National Hotel & Convention Center

 

Organizers

Organized in collaboration with the Global Resource for Advancing Cancer Education (GRACE) and the Melanoma Research Alliance (MRA).

Program Purpose

This forum educated cancer patients and their caregivers about the latest advances in immunotherapy treatment. Leading experts in the cancer immunotherapy field presented on how immunotherapy works and explained the latest treatment options available now and on the horizon.

In addition to general didactic sessions, the forum included specific breakout sessions that covered the unique issues facing melanoma, leukemia, genitourinary and lung cancer patients. Given the recent advancements in the field, the goal was to spread awareness and educate patients about immunotherapy treatment options – empowering patients to be actively involved in all levels of their care.                                                                                                                

Presented by

Advocacy Partners

	Melanoma International Foundation

The Immunotherapy Patient Forum for the Treatment of Melanoma, Leukemia, Lymphoma, Lung and Genitourinary Cancers was supported in part by grants from Amgen; Bristol-Myers Squibb; Genentech; Novartis Pharmaceuticals Corporation; Pfizer/Merck KGaA; and Prometheus Lab, Inc.